File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC‑1 cells through the EphrinB1‑EphB2 pathway.

TitleHigh expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC‑1 cells through the EphrinB1‑EphB2 pathway.
Authors
KeywordsErythropoietin-producing hepatoma cell line-B2
Pancreatic cancer
Predictive factor
Qingyihuaji formula
Issue Date2014
PublisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/ol
Citation
Oncology Letters, 2014, v. 8 n. 1, p. 17-24 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/201653
ISSN
2023 Impact Factor: 2.5
2023 SCImago Journal Rankings: 0.644
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHua, YQen_US
dc.contributor.authorChen, Zen_US
dc.contributor.authorMeng, ZQen_US
dc.contributor.authorChen, Hen_US
dc.contributor.authorShen, JGen_US
dc.contributor.authorWang, Ken_US
dc.contributor.authorPeng, Wen_US
dc.contributor.authorShen, YHen_US
dc.contributor.authorLiu, LMen_US
dc.date.accessioned2014-08-21T07:34:07Z-
dc.date.available2014-08-21T07:34:07Z-
dc.date.issued2014en_US
dc.identifier.citationOncology Letters, 2014, v. 8 n. 1, p. 17-24en_US
dc.identifier.issn1792-1074-
dc.identifier.urihttp://hdl.handle.net/10722/201653-
dc.languageengen_US
dc.publisherSpandidos Publications. The Journal's web site is located at http://www.spandidos-publications.com/ol-
dc.relation.ispartofOncology Lettersen_US
dc.subjectErythropoietin-producing hepatoma cell line-B2-
dc.subjectPancreatic cancer-
dc.subjectPredictive factor-
dc.subjectQingyihuaji formula-
dc.titleHigh expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC‑1 cells through the EphrinB1‑EphB2 pathway.en_US
dc.typeArticleen_US
dc.identifier.emailShen, JG: shenjg@hku.hken_US
dc.identifier.authorityShen, JG=rp00487en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3892/ol.2014.2134-
dc.identifier.pmid24959213-
dc.identifier.pmcidPMC4063575-
dc.identifier.scopuseid_2-s2.0-84901238184-
dc.identifier.hkuros233587en_US
dc.identifier.volume8en_US
dc.identifier.issue1en_US
dc.identifier.spage17en_US
dc.identifier.epage24en_US
dc.identifier.isiWOS:000338179100004-
dc.publisher.placeGreece-
dc.identifier.issnl1792-1074-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats